Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
FPIs sell stake in Manpasand Beverages; Nomura, Parvest Equity exit

2018-07-10 thehindubusinessline
Foreign portfolio investors (FPIs) have sharply reduced their stake in SAIF Partners-backed Manpasand Beverages to 13.35 per cent in the June quarter with entities such as Nomura and Parvest Equity India exiting the company.
MANPASAND 539207

0
Manpasand Beverages Limited - Shareholders meeting

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MANPASAND 539207

0
Manpasand Beverages eyes global expansion, says ready to take on giants

2018-07-01 moneycontrol
Manpasand Beverages, makers of Mango Sip fruit drink, plans to expand aggressively across India and abroad and also enhance its production capacity, after stitching an ambitious distribution pact with Parle Products for the domestic market.
MANPASAND 539207

44
Closing Bell: Nifty ends June series below 10,600, Sensex dips 179 pts; Midcap index falls 2%

2018-06-28 moneycontrol
Market Closing: Benchmark indices ended sharply lower on the expiry day of June futures & options contracts, dragged by banking & financials and Reliance Industries. Weakness in the rupee and lingering trade tensions between the US and China also dented market sentiment.
BAJAJ-AUTO 500325 533096 KAJARIACER TCHQY 531548 FEDA 532755 539437 JUSTDIAL 532483 532480 FEDS BJJQY 500570 FEDERALBNK EICHERMOT CLNDY RLNIY ASHOKLEY ALBK FDBAY AKLD CNRYY TECHM BAJFINANCE TATASTEEL TATLY 500180 KOTAKBANK CANBK COALINDIA AKLS SOMANYCERA 500469 RELIANCE 532977 533278 505200 500470 535648 IDFCBANK 512529 RIGD 500233 HDFCBANK 500477 SEQUENT TATAMOTORS 500034 ECQRY HINDALCO KMBKY IBN 539207 HNDNF ICICIBANK TTST HDB 532174 ADANIPOWER 500247 MANPASAND JSTQY 500440 TTM

0
Manpasand Beverages Limited - Updates

2018-06-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MANPASAND 539207

0
Manpasand Beverages Limited - Press Release

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MANPASAND 539207

22
Closing Bell: Banks, oil, infra stocks drag Sensex 273 pts; Nifty ends below 10,700 ahead of FO expiry

2018-06-27 moneycontrol
On the global front, Asian markets closed lower, led by the drop in Chinese stocks amid lingering trade worries. China's Shanghai Composite was down 1.11 percent and Hong Kong's Hang Seng shed 1.82 percent while Japan's Nikkei lost 0.3 percent.
JUBILANT 500325 JIPKY 533096 MGHOF HCTHY 530019 532712 512599 SYNDIBANK RCOM 506590 532281 PHILIPCARB BJJQY RLNIY ANNRY 532947 JETAIRWAYS IRB 532865 532622 JSWSTEEL BAJAJFINSV 532276 BAJFINANCE HCLTECH HCCC 532939 ADANIENT 500228 RELIANCE IDBI 532617 532978 IBRQY RIGD 500034 RPOWER 500116 IBN JPASSOCIAT 539207 532532 M30 ICICIBANK GDL 532174 ADANIPOWER MANPASAND MEGH

0
Manpasand Beverages Limited - Dividend

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MANPASAND 539207

0
Manpasand Beverages Limited - Financial Result Updates

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
MANPASAND 539207

0
Will Manpasand results clear Deloitte doubts?

2018-06-26 thehindubusinessline
The board of Manpasand Beverages will meet on Wednesday to consider and approve audited financial results along with audited report for the fourth quarter and year ended March 31, 2018.
MANPASAND 539207

21
Sensex closes lower by 115 pts amid trade war fears; all eyes on OPEC meeting

2018-06-21 moneycontrol
The market ended the volatile session on a negative note Thursday, weighed down by ITC, Larsen & Toubro and select banks. Investors closely monitor trade developments between the US and China, and await OPEC decision due tomorrow.
500325 AXB KMBKY IBN RELIANCE CANFINHOME 511196 532215 539207 AXBKY AXBA ICICIBANK AXISBANK 532174 RIGD KOTAKBANK 500247 MANPASAND RLNIY

23
Closing Bell: Sensex loses 115 pts, Nifty ends below 10,750; ITC, LT shares drag

2018-06-21 moneycontrol
Global Update: Asian markets closed mixed as investors monitor trade developments between world's largest economies US and China. China's Shanghai Composite, Hong Kong's Hang Seng and South Korea's Kospi closed down over a percent while Japan's Nikkei gained 0.6 percent and Australia's ASX 200 rose 1 percent.
INDIANB 500325 533096 RELIANCE IDBI 512573 532814 532832 533278 JUSTDIAL 535648 RIGD HDFCBANK CLNDY RLNIY UBNC 500116 AVANTI 534690 IBN 532942 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 ADANIPOWER COALINDIA JSTQY MANPASAND IBREALEST

16
Market Live: Sensex falls 100 pts, Nifty below 10,750; crude dips 2% ahead of OPEC meet

2018-06-21 moneycontrol
Further, reports of the bank appointing a law firm and risk assessment company to assist the independent enquiry against its CEO soothed market investors.
500325 534690 IBN RELIANCE 532942 539207 KNRCON ICICIBANK LAKSHVILAS HDB 532174 500180 RIGD HDFCBANK MANPASAND RLNIY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...